ebastine and idelalisib

ebastine has been researched along with idelalisib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Angelone, T; Avolio, E; Barbieri, A; Botti, G; De Bartolo, A; De Lorenzo, A; Gualtieri, P; Palma, G; Pasqua, T; Rocca, C; Silvestri, G1

Reviews

1 review(s) available for ebastine and idelalisib

ArticleYear
PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Butyrophenones; Class I Phosphatidylinositol 3-Kinases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Inflammation; Interleukin-6; Molecular Targeted Therapy; Pandemics; Peptidyl-Dipeptidase A; Piperidines; Pneumonia, Viral; Purines; Quinazolinones; SARS-CoV-2

2020